Journey Medical earnings missed by $0.07, revenue fell short of estimates
Journey Medical (NASDAQ: DERM) reported third-quarter EPS of $-0.050, missing analyst estimates by $0.07, and revenue of $19 million, falling short of the consensus estimate of $21.9 million. The company's stock price has declined -34.670% in the last 3 months and -42.910% in the last 12 months, despite seeing both positive and negative EPS revisions in the past 90 days. InvestingPro rates Journey Medical's financial health as "fair performance."
Put this headline into context
Use TradingAgents AI to connect the story to the company's filings, fundamentals, market structure, competing bull and bear arguments, and risk review.
Headlines and excerpts belong to the original publisher. Ticker associations are informational and may be incomplete. Market news is not personalized financial advice.